Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: Cancer Prev Res (Phila). 2014 Apr 25;7(7):686–697. doi: 10.1158/1940-6207.CAPR-13-0359

Table 2.

Technical and professional costs associated with tumor testing, genetic counseling, and germline testing of endometrial carcinomas.

Medicare reimbursement amounts Cost with SGO Screening
N = 97
Cost for Universal Screening
N = 412
Initial genetic counseling consultation (1 hr)a $192.67 $18,688.99 $8,862.82
Follow-up genetic counseling visits (30 min)a $105.20 $11,151.20 $4,628.80
IHC for MLH1, MLH2, MSH6, and PMS2b $422.08 $40,941.76 $173,896.96
MLH1 promoter methylation assay for tumor with IHC loss of MHL1c $90.25 $1,173.25 $8122.50
Single gene germ-line testingd $1300 $19,500 $57,200
Single site testinge,f $475 N/A N/A
a

Medicare does not reimburse for genetic counseling. Costs shown are estimates for genetic counseling before genetic testing.

b

CPT code 88342 used for each individual IHC DNA MMR protein

c

CPT stack codes 83900, 83909, 83912 used in 2012 (no longer effective 01/2013).

d

Cost of germline testing was obtained from Myriad ABN worksheet

e

Cost of single site testing was obtained from Myriad ABN worksheet

f

Single site testing intended for first degree relatives of patients with endometrial cancer who were identified as having Lynch Syndrome based upon positive germline test results